These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11582577

  • 21. Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport.
    Rao RK, Levenson S, Fang SN, Hruby VJ, Yamamura HI, Porreca F.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1003-9. PubMed ID: 8113956
    [Abstract] [Full Text] [Related]

  • 22. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 1994 Feb; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 23. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M, Liu G, Pinon DI, Miller LJ.
    Biochemistry; 2005 May 03; 44(17):6693-700. PubMed ID: 15850403
    [Abstract] [Full Text] [Related]

  • 24. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58.
    Reeve JR, McVey DC, Bunnett NW, Solomon TE, Keire DA, Ho FJ, Davis MT, Lee TD, Shively JE, Vigna SR.
    Pancreas; 2002 Oct 03; 25(3):e50-5. PubMed ID: 12370550
    [Abstract] [Full Text] [Related]

  • 25. Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy.
    Pellegrini M, Mierke DF.
    Biochemistry; 1999 Nov 09; 38(45):14775-83. PubMed ID: 10555959
    [Abstract] [Full Text] [Related]

  • 26. The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies.
    Agostini S, Bolzati C, Didonè E, Cavazza-Ceccato M, Refosco F, Aloj L, Arra C, Aurilio M, Tornesello AL, Tesauro D, Morelli G.
    J Pept Sci; 2007 Apr 09; 13(4):211-9. PubMed ID: 17269133
    [Abstract] [Full Text] [Related]

  • 27. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y, Bläker M, Seshadri L, McBride EW, Beinborn M, Kopin AS.
    J Mol Neurosci; 2003 Apr 09; 20(2):115-24. PubMed ID: 12794305
    [Abstract] [Full Text] [Related]

  • 28. Molecular modelling of CCK-A receptors.
    Van Der Bent A, Ijzerman AP, Soudijn W.
    Drug Des Discov; 1994 Nov 09; 12(2):129-48. PubMed ID: 9116168
    [Abstract] [Full Text] [Related]

  • 29. Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.
    Harikumar KG, Dong M, Cheng Z, Pinon DI, Lybrand TP, Miller LJ.
    Biochemistry; 2006 Dec 12; 45(49):14706-16. PubMed ID: 17144663
    [Abstract] [Full Text] [Related]

  • 30. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
    Schäfer U, Harhammer R, Boomgaarden M, Sohr R, Ott T, Henklein P, Repke H.
    J Neurochem; 1994 Apr 12; 62(4):1426-31. PubMed ID: 8133271
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and biological evaluation of cyclic and branched peptide analogues as ligands for cholecystokinin type 1 receptor.
    De Luca S, De Capua A, Saviano M, Della Moglie R, Aloj L, Tarallo L, Pedone C, Morelli G.
    Bioorg Med Chem; 2007 Sep 01; 15(17):5845-53. PubMed ID: 17562367
    [Abstract] [Full Text] [Related]

  • 32. High affinity binding of cholecystokinin to small cell lung cancer cells.
    Yoder DG, Moody TW.
    Peptides; 1987 Sep 01; 8(1):103-7. PubMed ID: 3033616
    [Abstract] [Full Text] [Related]

  • 33. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN, St-Pierre S, Gaudreau P.
    J Pharmacol Exp Ther; 1984 Aug 01; 230(2):438-44. PubMed ID: 6086888
    [Abstract] [Full Text] [Related]

  • 34. Intermolecular interactions between peptidic and nonpeptidic agonists and the third extracellular loop of the cholecystokinin 1 receptor.
    Giragossian C, Sugg EE, Szewczyk JR, Mierke DF.
    J Med Chem; 2003 Jul 31; 46(16):3476-82. PubMed ID: 12877585
    [Abstract] [Full Text] [Related]

  • 35. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
    McCort-Tranchepain I, Ficheux D, Durieux C, Roques BP.
    Int J Pept Protein Res; 1992 Jan 31; 39(1):48-57. PubMed ID: 1378822
    [Abstract] [Full Text] [Related]

  • 36. Models for the A- and B-receptor-bound conformations of CCK-8.
    Nikiforovich GV, Hruby VJ.
    Biochem Biophys Res Commun; 1993 Jul 15; 194(1):9-16. PubMed ID: 8333874
    [Abstract] [Full Text] [Related]

  • 37. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ.
    Mol Pharmacol; 2004 Sep 15; 66(3):545-52. PubMed ID: 15322246
    [Abstract] [Full Text] [Related]

  • 38. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor.
    Giragossian C, Mierke DF.
    Biochemistry; 2002 Apr 09; 41(14):4560-6. PubMed ID: 11926817
    [Abstract] [Full Text] [Related]

  • 39. Sulfated cholecystokinin octapeptide in the rat: pontomedullary distribution and modulation of the respiratory pattern.
    Ellenberger HH, Smith FM.
    Can J Physiol Pharmacol; 1999 Jul 09; 77(7):490-504. PubMed ID: 10535709
    [Abstract] [Full Text] [Related]

  • 40. The first nonsulfated sulfakinin activity reported suggests nsDSK acts in gut biology.
    Nichols R.
    Peptides; 2007 Apr 09; 28(4):767-73. PubMed ID: 17292511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.